Valuation: Circio Holding ASA

Market Cap 1.89B 192M 168M 154M 144M 273M 18.3B 277M 1.85B 721M 9B 722M 706M 31B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.89B 192M 168M 155M 144M 273M 18.33B 278M 1.86B 722M 9.01B 722M 707M 31.04B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+4.89%
1 week+4.34%
Current month+7.73%
1 month-5.48%
3 months-26.48%
6 months+550.82%
Current year+582.13%
1 week 7.17
Extreme 7.17
8.17
1 month 6.94
Extreme 6.94
8.77
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
246.3
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/11/21Fiscal year

Chief Executive Officer

120,000 0.1386%
19/05/21Buy

Director

21,299 0.0246%
03/12/20Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+4.89%+4.34%+1,166.35%-53.89% 192M
+0.68%+5.92%+77.86%+139.22% 59.1B
+2.32%+5.03%+75.26%+91.40% 55.19B
+3.86%+6.93%-11.32%-9.53% 24.67B
+4.30%+7.95%+14.11%+437.83% 24.19B
+4.74%+13.68%+43.36%-4.67% 19.69B
-0.29%+9.78%+43.90%-28.41% 17.56B
0.00%+20.78%+186.15%+361.42% 16.22B
+6.72%+19.38%+37.85% - 14.84B
+3.50%+1.97%+21.02%+191.95% 14.04B
Average +3.07%+8.14%+165.45%+125.04% 24.57B
Weighted average by Cap. +2.46%+6.47%+59.19%+136.82%

Financials

2024 2025
Net sales - -
Net income 57.52M 5.85M 5.11M 4.7M 4.38M 8.31M 557M 8.44M 56.43M 21.94M 274M 21.96M 21.49M 944M -45.91M -4.67M -4.08M -3.75M -3.5M -6.63M -445M -6.73M -45.03M -17.51M -219M -17.53M -17.15M -753M
Net Debt -972K -98.86K -86.42K -79.42K -74.03K -140K -9.41M -143K -953K -371K -4.63M -371K -363K -15.94M 2.24M 228K 200K 183K 171K 324K 21.74M 329K 2.2M 856K 10.69M 857K 839K 36.83M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
03/07/26 NOK 7.940 +4.89% 5,609,934
02/07/26 NOK 7.570 +2.16% 3,404,702
01/07/26 NOK 7.410 +0.54% 1,998,140
30/06/26 NOK 7.370 -1.07% 4,280,344
29/06/26 NOK 7.450 -2.10% 3,324,258

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock